JACC-CARDIOONCOLOGY

|

Elsevier
Netherlands
MEDICINE
Significant Science Journal
English
Gold OA
T1
/

Publishing Information

/
Singe-blind

Founding year

/

Publishing Frequency

/

Number of articles per year

136

(2023)

Rejection Rate

0%

(2024)

Open Access

CC BY | CC BY-NC-ND

Content

Research Article; Review; Short Communication
No
reproducible
Open Submission
JACC: CardioOncology is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC) . It serves to advance the cardiovascular care of cancer patients through the publication of rigorously executed, innovative science and dissemination of evidence-based knowledge. The journal seeks to transform the field of cardio-oncology and actively engage and educate the cardiovascular and oncology communities in pre-clinical, translational, and clinical research, as well as in best practices in cardio-oncology. Broad areas of interest include original research studies in disease mechanisms, in vitro and in vivo model systems, novel and conventional therapeutics (Phase I-IV), epidemiology, precision medicine, and primary and secondary prevention. Disease states of interest include, but are not limited to amyloidosis, cardiovascular risk factors, heart failure, and vascular disease. The other specialist titles in this series are: • JACC: Basic to Translational Science • JACC: Cardiovascular Imaging • JACC: Cardiovascular Interventions • JACC: Case Reports • JACC: Clinical Electrophysiology • JACC: Heart Failure